Prevalence and genetic analysis of thalassemia in neonates in Wuhan area: a national megacity in central China

References

• Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379(9813):373–383.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. Keynote address: the challenge of thalassemia for the developing countries. Ann N Y Acad Sci. 2005;1054(1):11–17.
   PubMed Web of Science ®Google Scholar
• Riewpaiboon A, Nuchprayoon I, Torcharus K, et al. Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children. BMC Res Notes. 2010;3(1):29.
   PubMedGoogle Scholar
• Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
   PubMed Web of Science ®Google Scholar
• Hardison RC, Chui DH, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–233.
   PubMed Web of Science ®Google Scholar
• Suchdev PS, Ruth LJ, Earley M, et al. The burden and consequences of inherited blood disorders among young children in western Kenya. Matern Child Nutr. 2014;10(1):135–144.
   PubMed Web of Science ®Google Scholar
• Cao A, Rosatelli MC, Galanello R. Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: the Sardinian experience. Ciba Found Symp. 1996;197(197):137–151.
   PubMedGoogle Scholar
• Lau YL, Chan LC, Chan YY, et al. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong – implications for population screening. Int J Gynecol Obstet. 1997;59(1):1298–1301.
   Google Scholar
• Kwan Ma ES, Yin Chan AY, Yin Ha S, et al. Screening for (-SEA) alpha-globin gene deletion in beta-thalassemia carriers and prevention of hydrops fetalis. Haematologica. 2000;85(9):991–993.
   PubMed Web of Science ®Google Scholar
• Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
   PubMed Web of Science ®Google Scholar
• Lin M, Wen YF, Wu JR, et al. Hemoglobinopathy: molecular epidemiological characteristics and health effects on Hakka people in the Meizhou region, southern China. PLOS One. 2013;8(2):e55024.
   PubMed Web of Science ®Google Scholar
• Lin M, Zhong TY, Chen YG, et al. Molecular epidemiological characterization and health burden of thalassemia in Jiangxi Province, P.R. China. PLOS One. 2014;9(7):e101505.
   PubMed Web of Science ®Google Scholar
• Huang SW, Liu XM, Li GF, et al. Spectrum of β-thalassemia mutations in Guizhou Province, PR China, including first observation of codon 121 (GAA > TAA) in Chinese population. Clin Biochem. 2013;46(18):1865–1868.
   PubMed Web of Science ®Google Scholar
• Yao XY, Yu J, Chen SP, et al. Prevalence and genetic analysis of α-thalassemia and β-thalassemia in Chongqing area of China. Gene. 2013;532(1):127–124.
   Web of Science ®Google Scholar
• Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360–362.
   PubMed Web of Science ®Google Scholar
• Wang W, Ma ES, Chan AY, et al. Single-tube multiplex-PCR screen for anti-3.7 and anti-4.2 α-globin gene triplications. Clin Chem. 2003;49(10):1679–1682.
   PubMed Web of Science ®Google Scholar
• De SV, Kattamis C, Canatan D, et al. β-thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis. 2017;9(1):e2017018.
   PubMed Web of Science ®Google Scholar
• GBD Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2015;388(10053):1459–1544.
   Web of Science ®Google Scholar
• Thein SL. Molecular basis of β thalassemia and potential therapeutic targets. Blood Cells Mol Dis. 2018;70(S1079):54–65.
   PubMed Web of Science ®Google Scholar
• Farashi S, Harteveld CL. Molecular basis of α-thalassemia. Blood Cells Mol Dis. 2018;70:43–53.
   PubMed Web of Science ®Google Scholar
• Yao H, Chen X, Lin L, et al. The spectrum of α- and β-thalassemia mutations of the Li people in Hainan Province of China. Blood Cells Mol Dis. 2014;53(1–2):16–20.
   PubMed Web of Science ®Google Scholar
• He S, Qin Q, Yi S, et al. Prevalence and genetic analysis of α- and β-thalassemia in baise region, a multi-ethnic region in Southern China. Gene. 2017;619:71–75.
   PubMed Web of Science ®Google Scholar
• Tang W, Zhang C, Lu F, et al. Spectrum of α-thalassemia and β-thalassemia mutations in the Guilin Region of southern China. Clin Biochem. 2015;48(16–17):1068–1072.
   PubMed Web of Science ®Google Scholar
• He S, Li J, Li DM, et al. Molecular characterization of α- and β-thalassemia in the Yulin region of Southern China. Gene. 2018;655:61–64.
   PubMed Web of Science ®Google Scholar
• Xu X M, Zhang X H, Chen L L. Guidelines for thalassemia prevention and control programme[J]. Beijing: People’s Military Medical Press; 2011.
   Google Scholar
• Lai K, Huang G, Su L, et al. The prevalence of thalassemia in mainland China: evidence from epidemiological surveys. Sci Rep. 2017;7(1):920.
   PubMed Web of Science ®Google Scholar
• Karimi M, Cohan N, De Sanctis VD, et al. Guidelines for diagnosis and management of beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014;31(7):583–596.
   PubMed Web of Science ®Google Scholar
• Nemtsas P, Arnaoutoglou M, Perifanis V, et al. Neurological complications of beta-thalassemia. Ann Hematol. 2015;94(8):1261–1265.
   PubMed Web of Science ®Google Scholar
• Traivaree C, Monsereenusorn C, Rujkijyanont P, et al. Genotype-phenotype correlation among beta-thalassemia and beta-thalassemia/HbE disease in Thai children: predictable clinical spectrum using genotypic analysis. JBM. 2018;9:35–41.
   Web of Science ®Google Scholar
• Xu C, Liao B, Qi Y, et al. Analysis of gene mutation types of α- and β-thalassemia in Fuzhou, Fujian Province in China. Hemoglobin. 2018;42(3):143–147.
   PubMed Web of Science ®Google Scholar
• Zhang J, He J, Mao X, et al. Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan Province of Southwestern China. BMJ Open. 2017;7(1):e013367.
   PubMed Web of Science ®Google Scholar
• He J, Zeng H, Zhu L, et al. Prevalence and spectrum of thalassaemia in Changsha, Hunan Province, China: discussion of an innovative screening strategy. J Genet. 2017;96(2):327–332.
   PubMed Web of Science ®Google Scholar
• Zhao P, Weng R, Wu H. Molecular spectrum of α- and β-thalassemia mutations in a large ethnic Hakka population in Southern China. Hemoglobin. 2018;42(2):117–121.
   PubMed Web of Science ®Google Scholar
• Choudhry VP. Quality of life in thalassemia major. Indian J Pediatr. 2018;85(11):957–958.
   PubMed Web of Science ®Google Scholar